89bio Inc Stock In The News

ETNB Stock  USD 9.64  0.91  10.42%   
Our overall analysis of 89bio's news coverage and content from conventional and social sources shows investors' bearish mood towards 89bio Inc. The specific impact of 89bio news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of 89bio's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using 89bio headlines in addition to utilizing other, more conventional financial analysis modules. Check out 89bio Backtesting and 89bio Hype Analysis.

89bio Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded Warrants
https://www.globenewswire.com/news-release/2025/01/29/3016874/0/en/89bio-Inc-Announces-Pricing-of-250-0-Million-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html
 Neutral
Macroaxis News: globenewswire.com
89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
https://www.globenewswire.com/news-release/2025/01/27/3015983/0/en/89bio-Inc-Announces-Proposed-Underwritten-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html
 Neutral
Yahoo News
Akero's Stock Skyrockets 112% After Game-Changing Liver Drug Data
https://finance.yahoo.com/news/akeros-stock-skyrockets-112-game-171334490.html
 Neutral
Yahoo News
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
https://finance.yahoo.com/news/whats-going-fattly-liver-disease-191750826.html
 Bullish
Yahoo News
11 Best Small-Cap Growth Stocks to Invest In
https://finance.yahoo.com/news/11-best-small-cap-growth-085546173.html
 Bullish
Yahoo News
89BIO (ETNB) Recently Broke Out Above the 20-Day Moving Average
https://finance.yahoo.com/news/89bio-etnb-recently-broke-above-143503734.html
 Bullish
Yahoo News
Does 89BIO (ETNB) Have the Potential to Rally 168.77% as Wall Street Analysts Expect?
https://finance.yahoo.com/news/does-89bio-etnb-potential-rally-145504293.html
 Bullish
Yahoo News
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
https://finance.yahoo.com/news/89bio-announces-inducement-grants-under-210500047.html
 Bullish
Yahoo News
89bio, Inc.'s (NASDAQ:ETNB) one-year returns climbed after last week's 7.0% gain, institutional investors must be happy
https://finance.yahoo.com/news/89bio-inc-nasdaq-etnb-one-112706565.html
 Bullish
Yahoo News
89bio Announces Closing of its Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
https://finance.yahoo.com/news/89bio-announces-closing-upsized-public-123000147.html
 Bullish

89bio Inc Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide 89bio and other traded companies coverage with news coverage. We help investors stay connected with 89bio headlines for the 31st of January to make an informed investment decision based on correlating the impacts of news items on 89bio Stock performance. Please note that trading solely based on the 89bio Inc hype is not for everyone as timely availability and quick action are needed to avoid losses.
89bio's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help 89bio Inc investors visualize upcoming and past events in order to time the market based on 89bio Inc noise-free hype analysis.
89bio stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the 89bio earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about 89bio that are available to investors today. That information is available publicly through 89bio media outlets and privately through word of mouth or via 89bio internal channels. However, regardless of the origin, that massive amount of 89bio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of 89bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of 89bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to 89bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive 89bio alpha.

89bio Largest EPS Surprises

Earnings surprises can significantly impact 89bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-05-09
2024-03-31-0.46-0.54-0.0817 
2023-11-08
2023-09-30-0.53-0.450.0815 
2024-08-05
2024-06-30-0.57-0.480.0915 
2020-05-13
2020-03-31-0.86-0.760.111 
2023-08-09
2023-06-30-0.41-0.52-0.1126 
2022-08-11
2022-06-30-1.05-1.23-0.1817 
View All Earnings Estimates

89bio Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to 89bio Inc Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
29th of January 2025
MASH momentum prompts 250 million raise for 89bio - The Pharma Letter
at news.google.com 
Macroaxis News
23rd of January 2025
Acquisition by Mcwherter Charles of 10000 shares of 89bio at 6.71 subject to Rule 16b-3
at MacroaxisInsider 
news
16th of January 2025
89bio Stock Price Down 4 percent Time to Sell
at thelincolnianonline.com 
Gurufocus Stories at Macroaxis
10th of January 2025
Empery Asset Management, LPs Strategic Acquisition in Critical Metals Corp
at gurufocus.com 
Google News at Macroaxis
31st of December 2024
Jane Street Group LLC Has 1.03 Million Stock Holdings in 89bio, Inc. - MarketBeat
at news.google.com 
Gurufocus Stories at Macroaxis
19th of December 2024
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635
at gurufocus.com 
Gurufocus Stories at Macroaxis
10th of December 2024
CEO Rohan Palekar Increases Stake in 89bio Inc with Recent Share Purchase
at gurufocus.com 
Macroaxis News
6th of December 2024
Acquisition by Rohan Palekar of 5000 shares of 89bio at 7.89 subject to Rule 16b-3
at MacroaxisInsider 
news
5th of December 2024
89bio, Inc. Shares Bought by Janus Henderson Group PLC
at thelincolnianonline.com 
Google News at Macroaxis
19th of November 2024
RA CAPITAL MANAGEMENT, L.P. Increases Stake in 89bio Inc - GuruFocus.com
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards 89bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, 89bio's short interest history, or implied volatility extrapolated from 89bio options trading.
When determining whether 89bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of 89bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of 89bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on 89bio Inc Stock:
Check out 89bio Backtesting and 89bio Hype Analysis.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 89bio. If investors know 89bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 89bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.96)
Return On Assets
(0.41)
Return On Equity
(0.73)
The market value of 89bio Inc is measured differently than its book value, which is the value of 89bio that is recorded on the company's balance sheet. Investors also form their own opinion of 89bio's value that differs from its market value or its book value, called intrinsic value, which is 89bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 89bio's market value can be influenced by many factors that don't directly affect 89bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 89bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 89bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 89bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.